CME Group (US.CME)
Capital Allocation Audit · Period: 2010 – 2026
Key Metrics
US.CME · YoY: 2026 H1 vs 2025 H1
| Metric | Value | YoY |
|---|---|---|
| FCF Conversion | 97.9% | → |
| ROE | 8.3% | ↑ |
| Cash Conversion | 100.3% | ↓ |
| D/E Ratio | 0.13 | → |
| Gross Margin | 87.3% | → |
US.CME (CME Group) | YoY: 2026 H1 vs 2025 H1 Metric Value YoY ---------------------------- FCF Conversion 97.9% → ROE 8.3% ↑ Cash Conversion 100.3% ↓ D/E Ratio 0.13 → Gross Margin 87.3% →
Key Metrics
US.CME (CME Group) | YoY: 2026 H1 vs 2025 H1
Metric Value YoY----------------------------FCF Conversion 97.9% →ROE 8.3% ↑Cash Conversion 100.3% ↓D/E Ratio 0.13 →Gross Margin 87.3% →Audit Dimensions
Unlimited Companies
AppleMicrosoftAlphabet-AAmazonNVIDIAMeta PlatformsTeslaBerkshire Hathaway-BJPMorganVisaJohnson & JohnsonWalmartProcter & GambleExxon MobilUnitedHealthHome DepotMasterCardPfizerAbbVieCoca-ColaPepsiCoCostcoNetflixAdvanced Micro DevicesSalesforceDisneyNikeBoeingCaterpillarGoldman SachsAlibabaPDD HoldingsJD.comNIO IncLi AutoBaiduTaiwan SemiconductorASML HoldingEli Lilly and CoBroadcomCiscoOracleIntelAT&TVerizonMerck & CoTexas InstrumentsUnited Parcel ServiceRTX CorpLowe's Companies